Morning Market Losers
Chyron (NASDAQ: CHYR) shares dipped 15.38% to $0.88 at 9:50 am. Chyron's trailing-twelve-month ROE is -11.24%.
Telik (NASDAQ: TELK) dropped 14.43% to $2.55. Telik has been granted orphan drug designation by the US FDA for the treatment of myelodysplastic syndrome.
hhgregg (NYSE: HGG) shares lost 10.52% to $7.06. hhgregg expects around 3.6% decline in its FQ3 net sales.
Acasti Pharma (NASDAQ: ACST) fell 10.26% to $2.42. Acasti Pharma's 52-week trading range is $1.21-3.99.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.